Keros Therapeutics Inc (KROS)

15.65 -0.77 (-4.69%) USD  |  NASDAQ  |  Dec 30, 16:00
15.65 0.00 (0.00%) After-Hours: 18:34
More

Keros Therapeutics PS Ratio (Forward)

PS Ratio (Forward) Chart

View PS Ratio (Forward) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio (Forward) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Forward PS Ratio Definition

View Forward PS Ratio Definition
Start Trial

Forward Price to Sales Ratio is the current stock price over the predicted sales per share. While similar to the price to sales ratio, this is a forward looking estimate of a company's sales.

Read full definition.

PS Ratio (Forward) Range, Past 5 Years

View PS Ratio (Forward) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio (Forward) Benchmarks

View PS Ratio (Forward) Benchmarks
Start Trial
Aptevo Therapeutics Inc --
Corcept Therapeutics Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Scholar Rock Holding Corp --
Trevi Therapeutics Inc --